Showing results (201-210 of 237) with videos related to

Sort By:
Pageof 24
Nature Genetics|July 20, 2010
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32Lucia Conde, Eran Halperin, Nicholas K Akers, et al.
Genetic Epidemiology|April 28, 2012
Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25Li-Shiun Chen, Nancy L Saccone, Robert C Culverhouse, et al.
Nature Genetics|August 4, 2009
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancerLaufey Amundadottir, Peter Kraft, Rachael Z Stolzenberg-Solomon, et al.
Nature Genetics|January 27, 2010
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33Gloria M Petersen, Laufey Amundadottir, Charles S Fuchs, et al.
International Journal of Cancer|September 5, 2025
Genetically determined body mass index is associated with diffuse large B-cell lymphoma in polygenic and Mendelian randomization analysesAmy Moore, Eleanor Kane, Lauren R Teras, et al.
Frontiers in Oncology|February 18, 2020
Genetically Determined Height and Risk of Non-hodgkin LymphomaAmy Moore, Eleanor Kane, Zhaoming Wang, et al.
Genome Medicine|February 1, 2021
A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancerEvangelina López de Maturana, Juan Antonio Rodríguez, Lola Alonso, et al.
Journal of Translational Genetics and Genomics|October 8, 2021
Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypesAmy Moore, Mitchell J Machiela, Moara Machado, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 23, 2023
Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian RandomizationSontoria D King, Swathi Veliginti, Martijn C G J Brouwers, et al.
Cancer Research|May 9, 2018
HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma SubtypesSophia S Wang, Mary Carrington, Sonja I Berndt, et al.
Pageof 24